Specimen requirement | Plasma |
Urine | Fluid | ||||
Adult patient: Heparin gel tube Minimum blood volume: 5 mL |
Spot
urine: Plain bottle Minimum volume: 10 mL 24 Hr urine: U2 bottle |
Spot
fluid: Plain bottle Minimum volume: 10 mL
|
|||||
Paediatric patient:
Paediatric heparin tube
Number of vials: 1
Minimum blood volume: 1.3 mL |
|||||||
Authorisation code required | No | No | No | ||||
24 Hr available service |
Yes
(Call extension: 3353 for express result) |
No | No | ||||
Method | Spectrophotometry | ||||||
Reference interval |
Plasma:
(Source: from local population study in 2008)
Urine:
12.9 - 44.0 mmol/day
(Source: Robert WL et al. Reference Information for the Clinical Laboratory. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th Edn. Burtis CA, Ashwood ER, Bruns DE eds. Elsevier Saunders 2006; 2251 - 2318) |
||||||
Clinical indication |
Plasma phosphate:
Urine phosphate: |
||||||
Result interpretation |
Plasma phosphate:
Decreased levels of phosphate are usually found in patients with primary hyperparathyroidism, in some cases of hypercalcaemia associated with malignancy, in renal tubular disorders and in patients using magnesium and aluminium containing antacids.
Levels may be decreased during prolonged intravenous therapy if phosphate supplementation is inadequate. Phosphate levels may also be decreased following a carbohydrate-rich meal, due to cellular uptake of phosphate.
Numerous other conditions can affect serum phosphate levels.
Urine phosphate:
Urinary phosphate varies with age, muscle mass, renal junction, PTH, time of day, and other factors.
Urinary excretion varies with diet and is essentially equivalent to dietary intake.
High PTH levels and renal tubular disorders will result in relatively increased phosphate excretion. |
||||||
Measurement of uncertainty | |||||||
Frequency of measurement | Daily |